The nation of Zimbabwe has rejected a significant American health deal valued at 367 million US dollars (£272m) over five years because of Washington's insistence on sensitive biological samples.
The decision came to light following a official document dated December was leaked, which showed Head of State Emmerson Mnangagwa felt the arrangement was "lopsided".
An official spokesman has since stated that the United States was requesting health data for research and commercial purposes while refused to share the benefits from any future medical innovations.
"We will now turn to the difficult and regrettable task of ending our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy said the US had furnished over $1.9bn in health funding to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has appealed for continued negotiations to reach a agreement agreeable to both sides so the country's vital HIV programme can be sustained.
Broader Context
Zimbabwe's decision comes after a similar case in Kenya, where a high court suspended a related health funding agreement after concerns were raised about the security of Kenyans' health data.
Since returning to the presidency last year, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).
USAID had overseen assistance for the American government, but Trump claimed its expenditure was "wasteful" and his government was pursuing direct bilateral deals to enhance transparency and accountability.
Based on statements, 16 nations in Africa have so far signed similar health pacts, constituting over $18.3bn in new funding.
Details of the Rejected Agreement
The funds for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this collaboration could have provided immense advantages for Zimbabwean communities, particularly the 1.2 million currently on HIV treatment via US-supported initiatives," the Ambassador added.
However, official spokesman Nick Mangwana said the arrangement was "asymmetrical".
"The proposal required Zimbabwe to surrender its genetic material and health information indefinitely, with no corresponding guarantee of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that could result from that shared data," he stated.
"In essence, our nation would supply the raw materials for scientific discovery with no certainty that the end products would be available to our people if a new disease outbreak emerge."
Sovereignty and Global Health
Mangwana further pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral health agreements were undermining structures previously established via the global health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing scheme created to manage future global health emergencies.
"This framework is designed to guarantee that when a nation contributes its information, the resulting advantages – such as vaccines and treatments – are shared equitably, not monopolised solely by those with the funds to develop them."
These objections over the US deal "are not meant as anti-American sentiment," he added.
"We are open to continued discussions with our American counterparts on how subsequent collaboration could be structured in a way that respects the sovereignty and interests of both nations."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the official position, but urged that negotiations must proceed considering much of the nation's HIV programmes were funded by international support.
"If technical issues arise, such as those involving data governance or agreement terms, these can often be addressed via technical clarification and negotiated safeguards," the group commented.
The situation highlights the ongoing tensions between receiving much-needed foreign assistance and protecting a country's data in an ever more data-driven world.